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Background: Discovering new biomarkers has a great role in improving early
diagnosis of Hepatocellular carcinoma (HCC). The experimental determination of
biomarkers needs a lot of time and money. This motivates this work to use in-silico
prediction of biomarkers to reduce the number of experiments required for
detecting new ones. This is achieved by extracting the most representative genes in
microarrays of HCC.
Results: In this work, we provide a method for extracting the differential expressed
genes, up regulated ones, that can be considered candidate biomarkers in high
throughput microarrays of HCC. We examine the power of several gene selection
methods (such as Pearson’s correlation coefficient, Cosine coefficient, Euclidean
distance, Mutual information and Entropy with different estimators) in selecting
informative genes. A biological interpretation of the highly ranked genes is done
using KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways, ENTREZ and
DAVID (Database for Annotation, Visualization, and Integrated Discovery) databases.
The top ten genes selected using Pearson’s correlation coefficient and Cosine
coefficient contained six genes that have been implicated in cancer (often multiple
cancers) genesis in previous studies. A fewer number of genes were obtained by the
other methods (4 genes using Mutual information, 3genes using Euclidean distance
and only one gene using Entropy). A better result was obtained by the utilization of
a hybrid approach based on intersecting the highly ranked genes in the output of all
investigated methods. This hybrid combination yielded seven genes (2 genes for
HCC and 5 genes in different types of cancer) in the top ten genes of the list of
intersected genes.
Conclusions: To strengthen the effectiveness of the univariate selection methods,
we propose a hybrid approach by intersecting several of these methods in a
cascaded manner. This approach surpasses all of univariate selection methods when
used individually according to biological interpretation and the examination of gene
expression signal profiles.Background
Microarray is a powerful technology for gene profiling. Being able to retrieve the gene
expression values of the whole genome and thus studying the molecular biology of tis-
sues can lead to diagnosis of different diseases [1]. Next to the value of microarrays in
understanding the biological processes underlying a specific disease, it has a great role© 2012 Abdel Samee et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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substance that has a characteristic feature as an objective indicator of a biological state,
such as normal physiological processes [2]. The most important advantage of Insilco
prediction of biomarkers using microarrays is minimizing the number of experimental
work required for detecting new biomarkers and thus saving much time and money.
In liver cancer, exploring gene expression patterns of samples from healthy patients
and others infected with Hepatocellular Carcinoma (HCC) has revealed a significant
difference in the expression of some genes from normal to tumour samples. Genes hav-
ing high variance between both classes of samples in their expression are informative
features that should be used in any further analysis as suggested biomarkers. Discover-
ing new biomarkers of HCC can help in early detection of this type of cancer. Early de-
tection of HCC is a vital issue as it can help patients in receiving therapeutic benefits
rather than curative surgery. Unfortunately, there is no effective biomarker for early de-
tection of HCC. The current diagnosing of HCC relies on detection of an inaccurate
biomarker, alpha-fetoprotein (AFP) [3]. Therefore, there is a need for detecting new re-
liable biomarkers for HCC.
Detection of biomarkers in the context of machine learning can be treated as a fea-
ture selection problem that tries to select features (markers) that can distinguish be-
tween different classes of data. The selected features are a list of genes that might be
informative for discriminating different types and subtypes of diseases. So we will refer
to feature selection all through this paper by gene selection.
A widely used approach for gene selection is the univariate selection approach [4,5].
Univariate selection approaches yield consistently better results than multivariate
approaches [6]. In the univariate approach, the relevance of each gene is determined in-
dividually. However, the multivariate approach such as Singular Value Decomposition
(SVD) and Principal Component Analysis (PCA) considers the interactions between
genes. Some of the univariate methods are: Pearson’s correlation coefficients, Euclidean
distance, Cosine coefficient, Entropy and Mutual information.
Discovery of biomarkers from microarrays data was studied in several publications
[4-7]. All of these research efforts were seeking for selecting informative genes as a pre-
requisite step of a high performance classifier. None have assessed the quality of the
gene selection methods from the point of retrieving relevant biomarkers known in the
biological databases. A research paper made a comparison between the univariate and
multivariate approaches in improving the accuracy of classification [6]. This work
employed seven microarrays datasets representing different types of cancer. They found
that the univariate methods surpassed the multivariate with five datasets. This was due
to the small number of samples relative to the number of genes being studied which is
always the case in microarrays. Another research work offered a combination between
the Correlation Coefficient, as a univariate selection approach, and the singular value
decomposition (SVD), as a multivariate approach [4]. However, they did not attain high
classification accuracy due to the dependency between samples of the microarrays data
being studied. So in our research, we focused on testing the Correlation Coefficient as
a gene selection method individually or integrated with other univariate gene selection
methods. A robust method of discovering new biomarker using the ensemble feature
selection techniques in support vector machine (SVM) classifier was also presented [2].
This method improved the performance of the classification of microarrays data.
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method is not suitable for studying high throughput microarrays data that almost con-
tain more than 20,000 genes. Another study by Cho et al. [5] presented a comparative
study of different gene selection methods (Pearson’s correlation coefficients, Euclidean
distance, Cosine coefficient, Mutual information and information gain). They used
three benchmarking datasets and tested the impact of using such gene selection meth-
ods on different classifiers. An ideal biomarker was assumed that had two values of 0
and 1, which might produce irrelevant correlation and cosine coefficient. So, in this
study we rather preferred to propose different values than those ones as well as
normalize the gene expression values when the Euclidean Distance and the Cosine Co-
efficient are being calculated.
To conclude, the scope of those previous publications was focused on benchmarking
data sets, which contains a few thousands of genes, to compare the adequacy of differ-
ent gene selection methods and usually assessed using different classifiers. Therefore,
we were motivated to expand the research to cover microarrays of HCC comprising a
huge number of genes by means of the proposed hybrid technique. We examined the
power of some of the previous methods (cf. [5]) in addition to different Entropy estima-
tors. Biological validation of the retained top ten lists of genes is proposed in our work
too. Moreover, the significance of signal profiles of the selected genes in both normal
and tumor samples were validated using t-test.
Briefly, we defined an ideal biomarker as a gene that has two discrete values, minus
one in normal samples and one in tumour samples. Genes with similar profile to the
ideal biomarker are selected using Pearson’s correlation coefficients, Euclidean distance,
Cosine coefficient, Entropy and Mutual information. Then they are ranked according
to their similarity with the ideal gene. Highly ranked genes from all methods are inter-
sected in a cascaded manner. Finally, the top ranked genes are examined by checking
their signal profiles and mining the biological databases for their existence as known
biomarkers.Methods
The steps of the proposed framework include pre-processing of Affymetrix files, gene
selection, gene ranking, finding common genes and gene validation through biological
interpretation and signal profiling. These steps are shown in Figure 1.Materials
Thirty five microarray samples were downloaded from Gene Expression Omnibus
(GEO) [8]. Nineteen of theses samples are taken from normal subjects. The remaining
sixteen samples are for subjects with HCC as a complication of HCV cirrhosis. This
data were collected on the Affymetrix HG-U133A 2.0 platform. The raw data in “.CEL”
format was collected from GEO are pre-processed using the Affy package provided by
Bioconductor [9].Ideal biomarker
Suppose we have a gene expression matrix that contains a set of genes' expression


























































Figure 1 The proposed hybrid technique.
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defined as a vector of Q values. An ideal up regulated biomarker can be defined as a
gene that having a value of minus one in normal samples and a value of one in tumour
samples. The ideal up regulated biomarker is a step up signal as shown in Figure 2.
Pearson's correlation coefficient
The similarity between the ideal up regulated biomarker, BIdeal, and a gene Y can be deter-














The Pearson's correlation coefficient, r, is always between −1 and +1. The closer the
(1)correlation is to +/−1, the closer to a perfect linear relationship.
Figure 2 An ideal up regulated biomarker.
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The similarity between two vectors can be determined by measuring the distance be-
tween them in the space. So, we used the Euclidean distance between BIdeal and all





 Þ BIdealiÞ2 ð2Þ
The gene expression values were first normalized (by subtracting the mean value of
each gene from all its values) before calculating the Euclidean distance between them
and BIdeal. In this manner, all values will be in the same range from −1 to 1 and an ac-
curate distance will be calculated.
Cosine coefficient
The Cosine coefficient can measure the dependency between BIdeal, and a gene Y as
seen in Equation 3. If the Cosine coefficient is zero, then they are independent and if
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In the same manner, all genes expression values were first normalized as mentioned
(3)above.
Mutual information
Informative genes can also be discovered by computing the Mutual information be-
tween all genes and BIdeal. The formula of calculating the Mutual information [11,12] is
given as,
IðBIdeal;YÞ ¼ H BIdealð Þ  H BIdealð jY Þ ð4Þ
In this formula, we need firstly need to calculateH BIdealð Þ , the entropy of BIdeal, and
the conditional entropy between BIdeal and a gene Y: H BIdealð jY Þ.
Table 1 Functional annotation of the top ten genes selected using Pearson's correlation coefficient and Cosine coefficient
Affy ID Gene symbol Entrez gene ID Gene type GO processes Oncology KEGG pathways
202988_s_at RGS1 5996 Protein coding Immune response CXCR4-mediated signaling events,
organism-specific biosystem Pathway
Interaction Database ID: [cxcr4_pathway]
208949_s_at LGALS3 3958 Protein coding Immune response,
cell adhesion, T-cell regulation
Skin cancer, Breast cancer, Colon
cancer, Lung cancer, Cervical cancer,
Colorectal cancer, Bladder cancer,
Thyroid cancer, Pancreatic cancer,
prostate cancer, HCC
Immune System, organism-specific
biosystem REACTOME ID: [REACT_6900]
217028_at, 211919_s_at CXCR4 7852 Protein coding inflammatory response,
response to viral
prostate cancer, kidney cancer,
Breast cancer, Lung cancer, bladder
cancer, Pancreatic cancer, Colorectal
cancer, Thyroide cancer, Qastric cancer
CXCR4-mediated signaling events,
organism-specific biosystem Pathway
Interaction Database ID: [cxcr4_pathway]
205798_at IL7R 3575 Protein coding Immune response HCV Primary immunodeficiency KEGG ID:
[hsa05340]
202157_s_at CELF2 10659 Protein coding Regulation of heart
contraction
Breast cancer, Colon Cancer mRNA processing, organism-specific
biosystemWikiPathways ID: [WP411]
209606_at CYTIP Protein coding Regulation of cell adhesion
202992_at C7 730 Protein coding Immune response Hepatoma cell lined Immune System, organism-specific
biosystem REACTOME ID: [REACT_6900]






















Table 2 Functional annotation of the top ten genes selected using Mutual information
Affy ID Gene symbol Entrez gene ID Gene type GO processes Oncology KEGG pathways
201034_at ADD3 120 Protein coding Drug response
201141_at GPNMB 10457 Protein coding negative regulation
of cell proliferation
Liver inflammation
201278_at, 201280_s_at DAB2 1601 Protein coding Prostate Cancer, Breast Cancer,
esophageal Cancer
201311_s_at SH3BGRL 6451 Protein coding EGFR1 Signaling Pathway, organism-specific
biosystemWikiPathways ID: [WP437]
201893_x_at DCN 1634 Protein coding Cell growth Colon Carcinoma, Breast Cancer (TGF-beta signaling pathway) KEGG ID: [hsa04350]
202157_s_at CELF2 10659 Breast cancer, Colon Cancer
202207_at Arl4c 10123 Protein coding
202336_s_at Pam 5066 Protein coding Response to drug
202403_s_at COL1A2 1278 Protein coding blood vessel development colorectal cancer, breast cancer Platelet Activation, organism-specific





















Table 3 Functional annotation of the top ten genes selected using Euclidean distance




DCN 1634 Protein coding Cell growth Colon Carcinoma,
Breast Cancer
(TGF-beta signaling pathway) KEGG ID:
[hsa04350]
202992_at C7 730 Protein coding Immune response Hepatoma cell lined Immune System, organism-specific biosystem
REACTOME ID: [REACT_6900]
201918_at SLC25A36, 55186, Protein coding
204319_s_at Rgs10, 6001 Protein coding G alpha (i) signalling events, organism-specific
biosystem REACTOME ID: [REACT_19231]
211368_s_at CASP1 834 Protein coding plays a central role in the
execution-phase of cell apoptosis.
Colorectal cancer Immune System, organism-specific biosystem
REACTOME ID: [REACT_6900]
218589_at LPAR6 10161 The protein encoded by this gene
belongs to the family of G-protein
coupled receptors, that are preferentially
activated by adenosine and uridine
nucleotides.
G alpha (q) signalling events, organism-specific
biosystem REACTOME ID: [REACT_18283]
212509_s_at mxra7 439921 Protein coding
201278_at DAB2 1601 Protein coding The down-regulation of DAB2 may play an

























Table 4 Functional annotation of the top ten genes selected using Empirical estimator of Entropy
Affy ID Gene symbol Entrez gene ID Gene type GO processes Oncology KEGG pathways
117_at HSPA7 3310 Protein coding Response to stress MAPK signalling pathway KEGG ID: [hsa04010]
1438_at EPHB3 2049 Protein coding central nervous
system projection
neuron axonogenesis
200033_at DDX5 1655 Protein coding Cell growth prostate cancer Direct p53 effectors, organism-specific biosystem
Pathway Interaction Database ID: [p53downstreampathway]
200055_at taf10 6881 Protein coding Viral reproduction HIV Infection, organism-specific biosystem REACTOME ID:
200060_s_at LOC643446 10921 Protein coding Metabolic process Metabolism of RNA, organism-specific biosystem
REACTOME ID: [REACT_21257]


























Table 5 Functional annotation of the top ten genes selected using the hybrid technique
Affy ID Gene symbol Entrez gene ID Gene type GO processes Oncology KEGG pathways
208949_s_at LGALS3 3958 Protein coding Immune response,
cell adhesion, T-cell regulation
Skin cancer, Breast cancer, Colon cancer,
Lung cancer, Cervical cancer, Colorectal
cancer, Bladder cancer, Thyroid cancer,
Pancreatic cancer, prostate cancer, HCC
Immune System, organism-specific biosystem
REACTOME ID: [REACT_6900]
202157_s_at CELF2 10659 Protein coding Regulation of heart contraction Breast cancer, Colon Cancer mRNA processing, organism-specific biosystem
WikiPathways ID: [WP411]
209606_at CYTIP Protein coding Regulation of cell adhesion





DCN 1634 Protein coding Cell growth Colon Carcinoma, Breast Cancer (TGF-beta signaling pathway) KEGG ID: [hsa04350]
211919_s_at CXCR4 7852 Protein coding inflammatory response,
response to viral
HCC, prostate cancer, kidney cancer,
Breast cancer, Lung cancer, bladder cancer,
Pancreatic cancer, Colorectal cancer,
Thyroide cancer, Qastric cancer
CXCR4-mediated signaling events, organism-
specific biosystem Pathway Interaction Database
ID: [cxcr4_pathway]
214247_s_at DKK3 Lung cancer, prostate cancer, breast
cancer, Head and neck cell carcinoma
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The Entropy is a measure of the uncertainty of a discrete random variable x. It is calcu-
lated via estimators. The estimator that is most commonly used is the Empirical esti-
mator. It is also called Maximum likelihood [13]. It is defined by,









where, nb xkð Þ is the number of data points in bin k, m is number of observations (the
number of gene expression values) and n is the number of bins. This method estimates
the probability of each gene by counting the number of values in each bin of compar-
able values. In this paper, the number of bins equals two as the informative genes
should have different expression values in normal samples than those in tumour
samples. Other entropy's estimators are: Miller-Madow, Shrink and Schurmann-Grass-
berger. The Miller-Madow Entropy estimator adds a correction bias to the Empirical
estimator. The Shrinkage Entropy estimator is a combination of two different estima-
tors: one with low variance and the other with low bias. The last examined estimator is
the Schurmann-Grassberger Entropy estimator. It uses the Dirichlet distribution which
is a generalization of Beta distribution [13-16].
Results
For each gene selection method, we calculated the similarity between the ideal gene
























































































Figure 3 Profiles of four genes of top ten genes selected using Pearson's correlation coefficient and
Cosine coefficient.
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So, the number of retrieved genes using this method was 2284 genes. We restricted the
number of selected genes using the other methods to the same number of genes. The
functional annotations of the top ten genes are mined through DAVID's functional an-
notation [17], ENTREZ [18] and KEGG pathways [19]. The results obtained from each
method are listed in Tables 1, 2, 3, 4 and 5. In each table, we listed for each gene in the
top ten lists its Affy ID, symbol, ENTREZ ID, type, Gene Ontology (GO) processes,
Oncology term and pathways. Signal profiles of first four genes in the top ten genes are
charted as shown in the figures section.Discussion
Biological interpretation
As observed from the biological details listed in Table 1, it is clear that top ten genes
selected by the Pearson correlation coefficient and Cosine coefficient are the same. This
is due to the high similarity between them according to Equations 1 and 3. Six of the
top ten genes selected using these two methods have been previously implicated in dif-



























































































































































































































Figure 5 Profiles of four genes of top ten genes selected using Mutual information.
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http://www.tbiomed.com/content/9/1/34IL7R and C7) have immune response process as one of their GO processes. Moreover,
two genes (IL7R and LGALS3) are related to liver disease as they were manipulated in
the literature of HCV and HCC. This derives the attention to the importance of carry-
ing up further biological investigation on these discovered genes.
In Table 2, a different set of genes were retrieved using Mutual information. Four
genes (DAB2, DCN, CELF2 and COL1A2) have appeared previously in cancers. An-
other gene (GPNMB) appeared to be involved with the liver inflammation. Two genes
(DCN and C7) as shown in Table 3 are common genes in the list retrieved using Eu-
clidean distance and Pearson's correlation coefficient methods. These two genes have
been involved in colon and breast carcinoma. DAB2 which is a regulator of ovarian car-
cinoma and has been implicated in prostate and breast cancer is a common gene in the
top ten genes selected using Euclidean distance and Mutual information.
The last method, Entropy using Empirical estimator, gave the lowest performance as
shown in Table 4. Only one gene (DDX5) of the top ten genes has been previously
implicated in prostate cancer.
For genes selected by the proposed hybrid technique, we can notice from Table 5 that
there are 7 genes (2 genes for HCC and 5 genes in different types of cancer) are
yielded. High portion of genes (LGALS3, CELF2, CYTIP, C7, DCN, CXCR4) retrieved
by Pearson's correlation coefficient appeared in the top ten list retrieved by the hybrid
technique. One gene (DCN) is common in the top ten list retrieved by Pearson's
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technique. This reveals the high importance of these genes as candidate biomarker for
HCC.Examination of signal profiles
The signal profiles charted in Figures 3, 4 and 5 of genes selected using Pearson's cor-
relation coefficient, Cosine coefficient; Euclidean distance and Mutual information
show a high similarity with the signal profile of the ideal biomarker. In these figures, all
signals have a step up shape. This derives us to consider these genes as up regulated
biomarkers for HCC. The significance level of these signals according to their p-values
in Table 6 shows the significance of the selected genes.
The signal profiles of genes selected using Entropy using Empirical estimator shown
in Figure 6a have a random shape. Also as seen in Figure 6b, 6c and 6d, the other esti-
mators of Entropy: Miller-Madow, Shrink, Schurmann-Grassberger gave a randomTable 6 The significance level of the first four genes in the top ten list
Gene selection method Gene symbol t-test p-value


















































































































































































































































































































































































































Figure 6 (a) Profiles of four genes of top ten genes selected using Empirical entropy estimator. (b) Profiles of four genes of top ten genes selected using Miller-Madow entropy estimator.
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http://www.tbiomed.com/content/9/1/34shapes too for their selected genes. These signals have comparable p-values as in
Table 6. These results reveal a low performance of Entropy. Without generalization, we
conclude that the Entropy is an inadequate gene selection method in our application.
Conclusions
The investigated methods of gene selection when used individually gave a comparable
performance while Entropy method provided fairly acceptable result with respect to
validating the results using the biological databases. Even more, by examining the signal
profiles of genes retrieved using Entropy with different estimators, the signals are found
to be visually non discriminating normal and tumour samples and this inspection was
emphasised using t-test statistics. Nevertheless, the proposed hybrid approach sur-
passed all of the proposed methods when used solely. We conclude that the proposed
technique is feasible when mining in a huge number of genes in high throughput
microarrays. The proposed framework has detected a list of only 172 informative genes
out of 22777 genes being studied. This list contains novel informative genes that are
suggested as biomarkers for HCC and thus deserve further lab investigation as a future
work.
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